C4 Therapeutics, Inc. (CCCC)

C4 Therapeutics Revenue

C4 Therapeutics had revenue of $6.64M in the quarter ending June 30, 2026, with 2.75% growth. This brings the company's total for the last twelve months to $35.04M, up 2.33% year-over-year. In the year 2025, C4 Therapeutics had annual revenue of $35.95M with 1.02% growth. That makes C4 Therapeutics the 30,397th largest company in the world by revenue and 4,025th in the United States.

• Revenue (ttm): $35.04M
• Revenue Growth: +2.33%
• P/S Ratio: 10.74
• Revenue / Employee: $336,913
• Employees: 104
• Market Cap: 376.46M

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	35.95M	363.00K	1.02%
Dec 31, 2024	35.58M	4.49M	14.43%
Dec 31, 2022	31.10M	-14.69M	-32.08%
Dec 31, 2021	45.79M	12.59M	37.93%
Dec 31, 2020	33.20M	11.81M	55.25%
Dec 31, 2019	21.38M	2.02M	10.42%
Dec 31, 2018	19.36M	-	-

Data Source: Fiscal.ai Last updated: Aug 11, 2026

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 22, 2026

Data Sources Report a data error